• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟氯喹对映体的血液学处置

Hematologic disposition of hydroxychloroquine enantiomers.

作者信息

Brocks D R, Skeith K J, Johnston C, Emamibafrani J, Davis P, Russell A S, Jamali F

机构信息

Faculty of Pharmacy, University of Alberta, Edmonton, Canada.

出版信息

J Clin Pharmacol. 1994 Nov;34(11):1088-97. doi: 10.1002/j.1552-4604.1994.tb01986.x.

DOI:10.1002/j.1552-4604.1994.tb01986.x
PMID:7876401
Abstract

Hydroxychloroquine (HCQ) is a racemic antiarthritic agent that has a long half-life (t1/2) in plasma and accumulates in blood cells. To study the relationships between HCQ concentrations in plasma, serum, and whole blood and to determine the optimal blood fraction to use for therapeutic drug monitoring of the drug, we studied the relative distribution of the HCQ enantiomers in various fractions of human blood under in vivo and in vitro conditions. Substantially greater concentrations of both enantiomers were found in serum as compared with plasma because of release via platelet activation. After in vitro incubations of the separated blood cells with HCQ, high concentrations of both enantiomers were found in leukocytes, and low concentrations in erythrocytes and platelets; the R:S ratio in vitro was near unity in all of the cells examined. Unlike the in vitro cellular uptake, the concentrations of HCQ in vivo were significantly lower and stereoselective (R:S ratio = 2). There was almost no drug in the polymorphonuclear cells (PMN) in vivo, despite a substantial uptake in vitro after incubation of separated cells. The enantiomeric (R:S) ratio in the urinary excretion of the enantiomers was significantly correlated with that in plasma. The plasma-protein binding of the enantiomers was stereoselective and complimented the cellular uptake findings; the unbound fraction was dependent on the plasma concentrations of alpha 1-acid glycoprotein, but not albumin. Although concentrations in whole blood correlated well with those in lymphocytes and monocytes (the proposed site of HCQ action), stronger correlations were found between concentrations in serum and in the mononuclear cells.

摘要

羟氯喹(HCQ)是一种消旋抗关节炎药物,其在血浆中的半衰期较长(t1/2),并在血细胞中蓄积。为了研究血浆、血清和全血中HCQ浓度之间的关系,并确定用于该药物治疗药物监测的最佳血液组分,我们研究了在体内和体外条件下HCQ对映体在人血各组分中的相对分布。由于通过血小板活化释放,血清中两种对映体的浓度均显著高于血浆。将分离的血细胞与HCQ进行体外孵育后,白细胞中发现两种对映体的浓度较高,而红细胞和血小板中的浓度较低;在所检测的所有细胞中,体外的R:S比值接近1。与体外细胞摄取不同,体内HCQ的浓度显著较低且具有立体选择性(R:S比值 = 2)。尽管分离的细胞在体外孵育后有大量摄取,但体内多形核细胞(PMN)中几乎没有药物。对映体尿排泄中的对映体(R:S)比值与血浆中的显著相关。对映体的血浆蛋白结合具有立体选择性,与细胞摄取结果相符;未结合部分取决于α1-酸性糖蛋白的血浆浓度,而不取决于白蛋白。虽然全血中的浓度与淋巴细胞和单核细胞(HCQ作用的假定部位)中的浓度相关性良好,但血清和单核细胞中的浓度之间的相关性更强。

相似文献

1
Hematologic disposition of hydroxychloroquine enantiomers.羟氯喹对映体的血液学处置
J Clin Pharmacol. 1994 Nov;34(11):1088-97. doi: 10.1002/j.1552-4604.1994.tb01986.x.
2
Stereoselective distribution of hydroxychloroquine in the rabbit following single and multiple oral doses of the racemate and the separate enantiomers.消旋体及其单一对映体单次及多次口服给药后,羟氯喹在兔体内的立体选择性分布。
Chirality. 1994;6(4):337-46. doi: 10.1002/chir.530060418.
3
Effect of experimental diabetes mellitus and arthritis on the pharmacokinetics of hydroxychloroquine enantiomers in rats.实验性糖尿病和关节炎对大鼠体内羟氯喹对映体药代动力学的影响。
Pharm Res. 1998 Jun;15(6):897-903. doi: 10.1023/a:1011928732588.
4
Plasma protein binding of the enantiomers of hydroxychloroquine and metabolites.羟氯喹及其代谢产物对映体的血浆蛋白结合情况。
Eur J Clin Pharmacol. 1993;44(5):481-4. doi: 10.1007/BF00315548.
5
Pharmacokinetics of mexiletine enantiomers in healthy human subjects. A study of the in vivo serum protein binding, salivary excretion and red blood cell distribution of the enantiomers.美西律对映体在健康人体受试者中的药代动力学。对映体的体内血清蛋白结合、唾液排泄及红细胞分布研究。
Xenobiotica. 1995 Nov;25(10):1127-42. doi: 10.3109/00498259509061913.
6
Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects.健康受试者单次口服消旋体后羟氯喹的对映体选择性处置。
Br J Clin Pharmacol. 1995 Aug;40(2):127-33. doi: 10.1111/j.1365-2125.1995.tb05768.x.
7
Distribution of the enantiomers of hydroxychloroquine and its metabolites in ocular tissues of the rabbit after oral administration of racemic-hydroxychloroquine.消旋羟氯喹口服给药后,羟氯喹对映体及其代谢产物在兔眼组织中的分布
Chirality. 1994;6(4):347-54. doi: 10.1002/chir.530060419.
8
Analytical and semi-preparative high-performance liquid chromatographic separation and assay of hydroxychloroquine enantiomers.羟氯喹啉对映体的分析及半制备高效液相色谱分离与测定
J Chromatogr. 1992 Oct 2;581(1):83-92. doi: 10.1016/0378-4347(92)80450-5.
9
Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats.羟氯喹及其对映体对健康和糖尿病大鼠肝脏匀浆胞质组分中胰岛素代谢的抑制作用。
Life Sci. 1999;64(5):325-35. doi: 10.1016/s0024-3205(98)00568-2.
10
Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate.多剂量消旋羟氯喹给药后类风湿关节炎患者体内羟氯喹对映体的处置情况。
Br J Clin Pharmacol. 1993 Jul;36(1):78-81. doi: 10.1111/j.1365-2125.1993.tb05897.x.

引用本文的文献

1
Refining lupus management: a comprehensive review of HCQ blood levels.优化狼疮管理:对羟氯喹血液水平的全面综述
Rheumatol Adv Pract. 2025 Jul 7;9(3):rkaf080. doi: 10.1093/rap/rkaf080. eCollection 2025.
2
Therapeutic drug monitoring of disease-modifying antirheumatic drugs in circulating leukocytes in immune-mediated inflammatory diseases.免疫介导的炎症性疾病中循环白细胞中疾病修饰抗风湿药物的治疗药物监测。
Inflammopharmacology. 2023 Aug;31(4):1789-1811. doi: 10.1007/s10787-023-01243-8. Epub 2023 May 9.
3
Hydroxychloroquine Blood Concentrations Can Be Clinically Relevant Also After Drug Discontinuation.
停药后羟氯喹血药浓度仍可能具有临床相关性。
Drugs R D. 2022 Jun;22(2):155-163. doi: 10.1007/s40268-022-00387-2. Epub 2022 May 13.
4
Population Pharmacokinetics of Hydroxychloroquine and 3 Metabolites in COVID-19 Patients and Pharmacokinetic/Pharmacodynamic Application.羟氯喹及其3种代谢产物在新冠肺炎患者中的群体药代动力学及药代动力学/药效学应用
Pharmaceuticals (Basel). 2022 Feb 21;15(2):256. doi: 10.3390/ph15020256.
5
Synthesis and evaluation of enantiomers of hydroxychloroquine against SARS-CoV-2 in vitro.合成并评估了对 SARS-CoV-2 具有体外抑制活性的羟氯喹对映异构体。
Bioorg Med Chem. 2022 Jan 1;53:116523. doi: 10.1016/j.bmc.2021.116523. Epub 2021 Nov 22.
6
Development and validation of an LC-MS/MS method for determination of hydroxychloroquine, its two metabolites, and azithromycin in EDTA-treated human plasma.建立并验证了一种 LC-MS/MS 方法,用于测定 EDTA 处理的人血浆中的羟氯喹、两种代谢物和阿奇霉素。
PLoS One. 2021 Mar 5;16(3):e0247356. doi: 10.1371/journal.pone.0247356. eCollection 2021.
7
Multi-Compartment Lymph-Node-on-a-Chip Enables Measurement of Immune Cell Motility in Response to Drugs.多隔室芯片上淋巴结可实现对免疫细胞对药物反应时运动性的测量。
Bioengineering (Basel). 2021 Jan 31;8(2):19. doi: 10.3390/bioengineering8020019.
8
Clearance of chloroquine and hydroxychloroquine by the Seraph® 100 Microbinda Affinity Blood Filter -a device approved for the treatment of COVID-19 patients.Seraph® 100 Microbinda Affinity 血液滤器清除氯喹和羟氯喹 - 一种获批准用于治疗 COVID-19 患者的设备。
Ther Apher Dial. 2021 Apr;25(2):237-241. doi: 10.1111/1744-9987.13549. Epub 2020 Jul 28.
9
Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.模拟评估治疗儿童 COVID-19 的新型治疗方法的药代动力学指导剂量。
JAMA Pediatr. 2020 Oct 1;174(10):e202422. doi: 10.1001/jamapediatrics.2020.2422. Epub 2020 Oct 5.
10
Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC-ESI-MS/MS: An application for pharmacokinetic studies.使用液相色谱-电喷雾串联质谱法同时定量小鼠血液和组织中的羟氯喹及其代谢物:在药代动力学研究中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jan 1;1072:320-327. doi: 10.1016/j.jchromb.2017.11.026. Epub 2017 Nov 23.